SHORT BOWEL SYNDROME AND INTESTINAL FAILURE IN ADULTS: ANATOMY-DRIVEN PHENOTYPES, ADAPTATION BIOLOGY, AND CONTEMPORARY INTESTINAL REHABILITATION

  • Bojan Stojanović Department of Surgery, Faculty of Medical Sciences, University of Kragujevac https://orcid.org/0000-0001-6115-612X
  • Ivana Milivojčević Bevc Institute for emergency medical care, Belgrade https://orcid.org/0009-0007-1346-126X
  • Milica Dimitrijević Stojanović Department of Pathology, Faculty of Medical Sciences, University of Kragujevac
  • Goran Čolaković Institute for emergency medical care, Belgrade
  • Ivana Stefanović Institute for emergency medical care, Belgrade
  • Bojana Stojanović Department of Pathological Physiology, University of Kragujevac, Faculty of Medical Sciences
  • Danijela Tasić-Uroš Institute for emergency medical care, Belgrade
DOI: https://doi.org/10.5937/halo31-64650
Keywords: Keywords: short bowel syndrome; chronic intestinal failure; home parenteral nutrition; colon in continuity; intestinal adaptation; teduglutide; high-output stoma.

Abstract


Short bowel syndrome (SBS) is the leading cause of chronic intestinal failure in adults and most commonly follows extensive small-bowel resection. The resulting loss of absorptive surface and regulatory feedback leads to a spectrum of malabsorption syndromes, ranging from compensated intestinal insufficiency to intestinal failure requiring long-term parenteral support. Clinical outcomes are determined less by residual length alone than by postoperative anatomy, particularly the presence of colon in continuity and preservation of distal ileum and the ileocecal region. The pathophysiology of SBS integrates reduced absorptive capacity, accelerated transit, gastric hypersecretion, disordered bile acid handling, microbiome perturbation, and impaired enteroendocrine signaling. Intestinal adaptation, driven by luminal nutrients and trophic hormones such as GLP-2, can partially restore function over months to years, enabling stepwise reduction of parenteral support in selected patients. Modern care is centered on structured intestinal rehabilitation delivered by multidisciplinary teams, combining individualized fluid–electrolyte strategy, optimized oral/enteral nutrition, targeted pharmacotherapy to control secretion and motility, prevention and management of catheter-related complications, and selective reconstructive surgery. Disease-modifying therapy with GLP-2 analogues can reduce parenteral support requirements in SBS-associated intestinal failure, while transplantation remains reserved for refractory, life-threatening complications. This review summarizes current concepts and evidence-based principles for diagnosis, phenotype stratification, rehabilitation, and long-term surveillance in adult SBS.

Keywords: short bowel syndrome; chronic intestinal failure; home parenteral nutrition; colon in continuity; intestinal adaptation; teduglutide; high-output stoma.

References

1. Cuerda C, Pironi L, Arends J, Bozzetti F, Gillanders L, Jeppesen PB, et al. ESPEN practical guideline: Clinical nutrition in chronic intestinal failure. Clin Nutr. 2021;40(9):5196-220.
2. Pironi L, Cuerda C, Jeppesen PB, Joly F, Jonkers C, Krznarić Ž, et al. ESPEN guideline on chronic intestinal failure in adults - Update 2023. Clin Nutr. 2023;42(10):1940-2021.
3. Iyer K, DiBaise JK, Rubio-Tapia A. AGA Clinical Practice Update on Management of Short Bowel Syndrome: Expert Review. Clin Gastroenterol Hepatol. 2022;20(10):2185-94.e2.
4. Lal S, Soop M, Cuerda C, Jeppesen P, Joly F, Lamprecht G, et al. Quality-of-care standards in adult type 3 intestinal failure caused by benign disease: A European society of clinical nutrition and metabolism (ESPEN) position paper. Clin Nutr ESPEN. 2024;63:696-701.
5. Solar H, Ortega ML, Gondolesi G. Current Status of Chronic Intestinal Failure Management in Adults. Nutrients. 2024;16(16).
6. Nightingale JM. Management of patients with a short bowel. World J Gastroenterol. 2001;7(6):741-51.
7. Verbiest A, Jeppesen PB, Joly F, Vanuytsel T. The Role of a Colon-in-Continuity in Short Bowel Syndrome. Nutrients. 2023;15(3).
8. Muff JL, Sokolovski F, Walsh-Korb Z, Choudhury RA, Dunn JCY, Holland-Cunz SG, et al. Surgical Treatment of Short Bowel Syndrome-The Past, the Present and the Future, a Descriptive Review of the Literature. Children (Basel). 2022;9(7).
9. Reznik E, Newberry C. Current treatment options for adult patients with short bowel syndrome: Do prebiotics, probiotics, and synbiotics play a role? Nutr Clin Pract. 2025;40(5):1053-63.
10. Khrais A, Ali H, Choi S, Ahmed A, Ahlawat S. D-Lactic Acidosis in Short Bowel Syndrome. Cureus. 2022;14(5):e25471.
11. Shakhsheer BA, Warner BW. Short Bowel Syndrome. Curr Treat Options Pediatr. 2019;5(4):494-505.
12. Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'Keefe S J, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143(6):1473-81.e3.
13. Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60(7):902-14.
14. Seidner DL, Fujioka K, Boullata JI, Iyer K, Lee HM, Ziegler TR. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study. Nutr Clin Pract. 2018;33(4):520-7.
15. Joly F, Nuzzo A, Bozzetti F, Cuerda C, Jeppesen PB, Lal S, et al. A multi-national survey of experience and attitudes towards managing catheter related blood stream infections for home parenteral nutrition. Clin Nutr ESPEN. 2023;57:126-30.
16. Gompelman M, Causevic E, Bleeker-Rovers CP, Wanten GJA. Catheter-related bloodstream infection management in patients receiving home parenteral nutrition: An observational cohort study. Clin Nutr ESPEN. 2022;50:155-61.
17. Fousekis FS, Mitselos IV, Christodoulou DK. New insights into intestinal failure-associated liver disease in adults: A comprehensive review of the literature. Saudi J Gastroenterol. 2021;27(1):3-12.
18. Frezet S, Hermabessière P, Kerlogot L, Wilsius E, Balde C, Pellet G, et al. Intestinal failure-associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study. JPEN J Parenter Enteral Nutr. 2025;49(4):507-16.
19. Grocholski C, Chambrier C, Lauverjat M, Acquaviva C, Abid N, Bergoin C, et al. Circulating Oxalate Levels in Short Bowel Syndrome as a Severity Marker of CKD. Kidney Int Rep. 2024;9(3):686-93.
20. Rudziński M, Ławiński M, Gradowski Ł, Antoniewicz AA, Słodkowski M, Bedyńska S, et al. Kidney stones are common in patients with short-bowel syndrome receiving long-term parenteral nutrition: A predictive model for urolithiasis. JPEN J Parenter Enteral Nutr. 2022;46(3):671-7.
21. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124(4):1111-34.
Published
2026/02/23
Issue
Vol. 31 No. 3 (2025): Scientific Journal of Emergency Medicine Halo 194
Section
Review articles
Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:

  1. Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.

  2. Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.

  3. Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).